Merck's biosimilar to AbbVie's Humira wins FDA approval
The U.S. Food and Drug Administration approved Merck& Co Inc's biosimilar to AbbVie Inc's blockbuster rheumatoid arthritis treatment Humira, the health agency said on Tuesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Arthritis | Food and Drug Administration (FDA) | Health | Humira | Merck | Rheumatoid Arthritis | Rheumatology